Crossref journal-article
Elsevier BV
Journal of Molecular Graphics and Modelling (78)
Bibliography

Tounge, B. A., Rajamani, R., Baxter, E. W., Reitz, A. B., & Reynolds, C. H. (2006). Linear interaction energy models for β-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms. Journal of Molecular Graphics and Modelling, 24(6), 475–484.

Authors 5
  1. Brett A. Tounge (first)
  2. Ramkumar Rajamani (additional)
  3. Ellen W. Baxter (additional)
  4. Allen B. Reitz (additional)
  5. Charles H. Reynolds (additional)
References 66 Referenced 21
  1. {'key': '10.1016/j.jmgm.2005.10.002_bib1', 'first-page': '113', 'article-title': 'Calculating binding free energy in protein–ligand interaction', 'volume': 'vol. 1', 'author': 'Raha', 'year': '2005'} / Calculating binding free energy in protein–ligand interaction by Raha (2005)
  2. 10.1021/cr00023a004 / Chem. Rev. / Free energy calculations: applications to chemical and biochemical phenomena by Kollman (1993)
  3. 10.2174/1386207013330661 / Comb. Chem. High Throughput Screening / The linear interaction energy method for predicting ligand binding free energies by Aqvist (2001)
  4. 10.1023/A:1027251719816 / Perspect. Drug Discov. / A priori prediction of ligand affinity by energy minimization by Holloway (1998)
  5. 10.1021/jp011480z / J. Phys. Chem. B / New linear interaction method for binding affinity calculations using a continuum solvent model by Zhou (2001)
  6. 10.1021/j100026a034 / J. Phys. Chem. / An extended linear response method for determining free energies of hydration by Carlson (1995)
  7. 10.1021/jm020513b / J. Med. Chem. / Calculation of the binding affinity of beta-secretase inhibitors using the linear interaction energy method by Tounge (2003)
  8. 10.1016/j.bmcl.2004.07.044 / Bioorg. Med. Chem. Lett. / Modeling the binding affinities of β-secretase inhibitors: application to subsite specificity by Rajamani (2004)
  9. 10.1021/jm049726m / J. Med. Chem. / Efficient evaluation of binding free energy using continuum electrostatics by Huang (2004)
  10. 10.1023/A:1007930623000 / J. Comput. Aided Mol. Des. / Ligand binding affinity prediction by linear interaction energy methods by Hansson (1998)
  11. 10.1016/S0065-3233(03)66004-3 / Adv. Protein Chem. / Free energy calculations and ligand binding by Brandsdal (2003)
  12. 10.1002/(SICI)1097-0134(19990215)34:3<395::AID-PROT11>3.0.CO;2-4 / Proteins Struct. Funct. Genet. / What determines the van der Waals coefficient beta in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations? by Wang (1999)
  13. 10.1021/jm960684e / J. Med. Chem. / Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method by Jones-Hertzog (1997)
  14. 10.1016/S0960-894X(01)00825-3 / Bioorg. Med. Chem. Lett. / Estimation of binding affinities for Celecoxib analogues with COX-2 via Monte Carlo-extended linear response by Wesolowski (2002)
  15. 10.1016/S0968-0896(99)00015-2 / Bioorg. Med. Chem. / Estimation of the binding affinities of FKBP12 inhibitors using a linear response method by Lamb (1999)
  16. 10.1021/jm9804174 / J. Med. Chem. / Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method by Smith (1998)
  17. 10.1038/399a023 / Nature / Translating cell biology into therapeutic advances in Alzheimer's disease by Selkoe (1999)
  18. 10.1152/physrev.2001.81.2.741 / Physiol. Rev. / Alzhiemer's disease: genes, proteins and therapy by Selkoe (2001)
  19. 10.1073/pnas.96.20.11049 / Proc. Natl. Acad. Sci. U.S.A. / Cellular mechanisms of β-Amyloid production and secretion by Sinha (1999)
  20. 10.1016/S0169-409X(02)00157-6 / Adv. Drug Del. Rev. / β-Secretase (BACE) as a drug target for Alzheimer's disease by Vassar (2002)
  21. 10.1016/S0896-6273(00)00051-9 / Neuron / Abeta-generating enzymes: recent advances in beta- and gamma-secretase research by Vassar (2000)
  22. {'key': '10.1016/j.jmgm.2005.10.002_bib22', 'first-page': '157', 'article-title': "The beta-secretase BACE. A prime drug target for Alzheimer's disease", 'volume': '17', 'author': 'Vassar', 'year': '2001', 'journal-title': 'J. Mol. Spectrosc.'} / J. Mol. Spectrosc. / The beta-secretase BACE. A prime drug target for Alzheimer's disease by Vassar (2001)
  23. {'key': '10.1016/j.jmgm.2005.10.002_bib23', 'first-page': '259', 'article-title': "Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization", 'volume': '17', 'author': 'Schenk', 'year': '2001', 'journal-title': 'J. Mol. Spectrosc.'} / J. Mol. Spectrosc. / Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization by Schenk (2001)
  24. 10.1016/S0065-7743(00)35005-9 / Annu. Rep. Med. Chem. / Secretase inhibitors as therapeutics for Alzheimer's disease by Olson (2000)
  25. 10.1172/JCI14402 / J. Clin. Invest. / Spotlight on BACE: the secretases as targets for treatment in Alzheimer's disease by Dingwall (2001)
  26. 10.1126/science.290.5489.150 / Science (Washington DC) / Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor by Hong (2000)
  27. 10.1021/bi026232n / Biochemistry / Crystal structure of memapsin 2 (beta-Secretase) in complex with an inhibitor OM00-3 by Hong (2002)
  28. 10.1021/jm0101803 / J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (beta-Secretase) by Ghosh (2001)
  29. 10.1016/j.bmcl.2004.10.084 / Bioorg. Med. Chem. Lett. / Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (β-secretase) by Ghosh (2005)
  30. 10.1021/jm0155695 / J. Med. Chem. / Design of substrate-based inhibitors of human β.-Secretase by Tung (2002)
  31. 10.1074/jbc.M101896200 / J. Biol. Chem. / Mechanism of inhibition of β-site amyloid precursor protein-cleaving enzyme (BACE) by a statine-based peptide by Marcinkeviciene (2001)
  32. 10.1006/jmbi.2000.3860 / J. Mol. Biol. / Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein β-Secretase by Sauder (2000)
  33. 10.1021/jm0101803 / J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase) by Ghosh (2001)
  34. 10.1021/bi015546s / Biochemistry / Subsite specificity of memapsin 2 (β-Secretase): Implications for inhibitor design by Turner (2001)
  35. 10.1517/13543784.10.4.593 / Expert Opin. Inv. Drug / β-Amyloid therapies in Alzheimer's disease by Jhee (2001)
  36. 10.1021/ja000300g / J. Am. Chem. Soc. / Design of potent inhibitors for human brain memapsin 2 (beta-secretase) by Ghosh (2000)
  37. 10.1006/bbrc.2000.2098 / Biochem. Biophys. Res. Commun. / Inhibitors of β-amyloid formation based on the β-secretase cleavage site by Abbenante (2000)
  38. 10.1021/ja0304493 / J. Am. Chem. Soc. / Determination of the active site protonation state of β-Secretase from molecular dynamics simulation and docking experiment: implications for structure-based inhibitor design by Park (2003)
  39. 10.2174/1568026024607490 / Curr. Top. Med. Chem. / Inhibition of BACE, a promising approach to Alzheimer by Roggo (2002)
  40. 10.1039/B304842J / Org. Biomol. Chem. / Synthesis of potent β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies by Tamamura (2003)
  41. 10.1074/jbc.M210471200 / J. Biol. Chem. / Kinetic Studies on β-Site amyloid precursor protein-cleaving enzyme (BACE) by Toulokhonova (2003)
  42. 10.1021/jm0304008 / J. Med. Chem. / Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-Secretase by Hom (2004)
  43. 10.1021/jm049817j / J. Med. Chem. / Modeling the protonation states of the catalytic aspartates in β-Secretase by Rajamani (2004)
  44. 10.1016/j.bmcl.2003.09.053 / Bioorg. Med. Chem. Lett. / KMI-008, A novel β-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides by Shuto (2003)
  45. 10.1021/jm0155695 / J. Med. Chem. / Design of substrate-based inhibitors of human β-secretase by Tung (2002)
  46. 10.1021/bi0151465 / Biochemistry / Subsite specificity of memapsin 2 (β-Secretase): Implications for inhibitor design by Turner (2001)
  47. {'key': '10.1016/j.jmgm.2005.10.002_bib47', 'first-page': '1', 'article-title': 'Human β-secretase (BACE) and BACE inhibitors', 'volume': '46', 'author': 'Varghese', 'year': '2003', 'journal-title': 'J. Med. Chem.'} / J. Med. Chem. / Human β-secretase (BACE) and BACE inhibitors by Varghese (2003)
  48. 10.1021/jm050142+ / J. Med. Chem. / Structure-based design synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics by Hanessian (2005)
  49. {'key': '10.1016/j.jmgm.2005.10.002_bib49', 'first-page': '515', 'article-title': 'Synthesis of β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies', 'volume': '41st', 'author': 'Kato', 'year': '2005', 'journal-title': 'Pep. Sci.'} / Pep. Sci. / Synthesis of β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies by Kato (2005)
  50. 10.1021/jm049379g / J. Med. Chem. / Structure-based design of potent and selective cell-permeable inhibitors of human β-Secretase (BACE-1) by Stachel (2004)
  51. 10.1016/j.bmcl.2003.09.037 / Bioorg. Med. Chem. Lett. / Design and synthesis of statine-containing BACE inhibitors by Hu (2003)
  52. 10.1021/jm0155695 / J. Med. Chem. / Design of substrate-based inhibitors of human β-Secretase by Tung (2002)
  53. 10.1021/jm0101803 / J. Med. Chem. / Structure-based design: potent inhibitors of human brain memapsin 2 (β-secretase) by Ghosh (2001)
  54. 10.1021/jm050499d / J. Med. Chem. / Discovery of cell-permeable non-peptide inhibitors of β-secretase by high-throughput docking and continuum rlectrostatics calculations by Huang (2005)
  55. 10.1016/j.bmc.2005.01.002 / Bioorg. Med. Chem. / Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with β-secretase by Zuo (2005)
  56. 10.1016/j.bmcl.2004.09.090 / Bioorg. Med. Chem. Lett. / Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability by Kimura (2005)
  57. 10.1006/jmbi.2000.3860 / J. Mol. Biol. / Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein β-Secretase by Sauder (2000)
  58. 10.2174/0929867023370149 / Cur. Med. Chem. / β-secretase as a therapeutic target for inhibitor drugs by Ghosh (2002)
  59. 10.1016/j.jmb.2004.08.018 / J. Mol. Biol. / Apo and inhibitor complex structures of BACE (β-secretase) by Patel (2004)
  60. Maestro, 2.0 2.0, 2001. Schrodinger, Inc., 1500 SW First Ave., Suite 1180, Portland, OR 97201.
  61. 10.1021/ja00214a001 / J. Am. Chem. Soc. / The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin by Jorgensen (1988)
  62. 10.1021/jp961992r / J. Phys. Chem. A / The GB/SA continuum model for solvation. a fast analytical method for the calculation of approximate Born radii by Qui (1997)
  63. FistDiscovery, 2.0 2.0, 2001. Schrodinger, Inc., 1500 SW First Ave., Suite 1180, Portland, OR 97201.
  64. 10.1023/A:1007929626986 / J. Comput. Aided Mol. Des. / Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases by Marelius (1998)
  65. 10.1021/jp953640a / J. Phys. Chem. / Validity of electrostatic linear response in polar solvents by Aqvist (1996)
  66. 10.1002/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO;2-H / J. Comput. Chem. / Calculation of sbsolute binding free energies for charged ligands and effects of long-range electrostatic interactions by Aqvist (1996)
Dates
Type When
Created 19 years, 9 months ago (Nov. 16, 2005, 7:24 a.m.)
Deposited 2 years, 3 months ago (May 5, 2023, 9:04 a.m.)
Indexed 2 weeks, 5 days ago (Aug. 3, 2025, 12:05 a.m.)
Issued 19 years, 3 months ago (May 1, 2006)
Published 19 years, 3 months ago (May 1, 2006)
Published Print 19 years, 3 months ago (May 1, 2006)
Funders 0

None

@article{Tounge_2006, title={Linear interaction energy models for β-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms}, volume={24}, ISSN={1093-3263}, url={http://dx.doi.org/10.1016/j.jmgm.2005.10.002}, DOI={10.1016/j.jmgm.2005.10.002}, number={6}, journal={Journal of Molecular Graphics and Modelling}, publisher={Elsevier BV}, author={Tounge, Brett A. and Rajamani, Ramkumar and Baxter, Ellen W. and Reitz, Allen B. and Reynolds, Charles H.}, year={2006}, month=may, pages={475–484} }